Helicobacter pyloriTest-and-Treat Program Can Be Cost-effective to Prevent Gastric Cancer in Taiwanese Adults: Referred to the Nationwide Reimbursement Database

Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials

(2014) A. C. Ford et al.   BMJ-British Medical Journal

Factors That Affect Life Expectancy of Patients With Gastric Adenocarcinoma

(2013) Wei–Ying Chen et al.   Clinical Gastroenterology and Hepatology

Screening for Gastric Cancer and Surveillance of Premalignant Lesions: a Systematic Review of Cost-Effectiveness Studies

(2013) Miguel Areia et al.   HELICOBACTER

Contribution of H. pylori and Smoking Trends to US Incidence of Intestinal-Type Noncardia Gastric Adenocarcinoma: A Microsimulation Model

(2013) Jennifer M. Yeh et al.   PLOS MEDICINE

The benefit of mass eradication ofHelicobacter pyloriinfection: a community-based study of gastric cancer prevention

(2012) Yi-Chia Lee et al.   GUT

Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report

(2012) Peter Malfertheiner et al.   GUT

Long-term Celecoxib can Prevent the Progression of Persistent Gastric Intestinal Metaplasia AfterH. pyloriEradication

(2012) Bor-Shyang Sheu et al.   HELICOBACTER

Beyond the target pathogen: ecological effects of the hospital formulary

(2011) Ellie JC Goldstein   CURRENT OPINION IN INFECTIOUS DISEASES

Early Helicobacter pylori Eradication Decreases Risk of Gastric Cancer in Patients With Peptic Ulcer Disease

(2009) Chun–Ying Wu et al.   GASTROENTEROLOGY

Host Single Nucleotide Polymorphisms ofMMP-9 −1562/TIMP-1372 Have Gender Differences in the Risk of Gastric Intestinal Metaplasia AfterHelicobacter pyloriInfection

(2009) Kuei-Hsiang Hung et al.   HELICOBACTER

Asia–Pacific consensus guidelines on gastric cancer prevention

(2008) Kwong Ming Fock et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY